Meredith L. Leong
- Immunology top 2%
- Molecular Biology top 10%
- Oncology top 10%
- Biotechnology top 2%
- Infectious Diseases top 5%
- Co-authors
- Thomas W. DubenskyGary L. FirestoneDavid B. KanneAnita C. MaiyarWeiqun LiuDaniel A. PortnoyBrian KimEdward E. Lemmens
- Topics
- interferon and immune responses (8 papers)Immunotherapy and Immune Responses (8 papers)Listeria monocytogenes in Food Safety (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Meredith L. Leong
27 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Immunology 1.1k
- Molecular Biology 907
- Oncology 443
- Biotechnology 326
- Infectious Diseases 326
Countries citing papers authored by Meredith L. Leong
This map shows the geographic impact of Meredith L. Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith L. Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith L. Leong more than expected).
Fields of papers citing papers by Meredith L. Leong
This network shows the impact of papers produced by Meredith L. Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith L. Leong. The network helps show where Meredith L. Leong may publish in the future.
Co-authorship network of co-authors of Meredith L. Leong
This figure shows the co-authorship network connecting the top 25 collaborators of Meredith L. Leong. A scholar is included among the top collaborators of Meredith L. Leong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith L. Leong. Meredith L. Leong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 67 | |
| 6 | 91 | |
| 7 | 70 | |
| 8 | STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockadebreakdown → | 581 |
| 9 | 151 | |
| 10 | 42 | |
| 11 | 35 | |
| 12 | 21 | |
| 13 | 7 | |
| 14 | Live-attenuated L. monocytogenes encoding mesothelin for immunotherapy of patients with pancreas and ovarian cancers | 3 |
| 15 | 48 | |
| 16 | 239 | |
| 17 | 45 | |
| 18 | 213 | |
| 19 | 177 | |
| 20 | 137 |
About Meredith L. Leong
Meredith L. Leong is a scholar working on Biotechnology, Immunology and Oncology, having authored 28 papers that have together received 2.0k indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), Immunotherapy and Immune Responses (8 papers) and Listeria monocytogenes in Food Safety (5 papers). The work is most often cited by research in Immunology (1.1k citations), Biotechnology (326 citations) and Infectious Diseases (326 citations). Meredith L. Leong has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Thomas W. Dubensky, Gary L. Firestone, David B. Kanne, Anita C. Maiyar, Weiqun Liu, Daniel A. Portnoy, Brian Kim, Edward E. Lemmens, Peter Lauer and Dirk G. Brockstedt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.